Discontinuation report ATRIPLA

Last updated on 2022-01-01 History
Report ID 144260
Drug Identification Number 02300699
Brand name ATRIPLA
Common or Proper name efavirenz/emtricitabine/tenofovir disoproxil fumarate
Company Name GILEAD SCIENCES, LLC
Market Status MARKETED
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ
Strength(s) 300MG 200MG 600MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Each bottle contains 30 tablets
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-12-31
Actual discontinuation date 2021-12-31
Remaining supply date 2021-12-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Sufficient supply to meet patient need to discontinuation date.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 333 LAKESIDE DRIVE
FOSTER CITY, CALIFORNIA
UNITED STATES 94404
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-01-01 English Compare
v3 2021-08-17 French Compare
v2 2021-08-17 French Compare
v1 2021-08-17 English Compare

Showing 1 to 4 of 4